Insider Trading Alert - RMD, PENN And PH Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, May 12, 2014, 142 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $463.50 to $302,316,738.76.

Highlighted Stocks Traded by Insiders:

ResMed (RMD) - FREE Research Report

Sandercock Brett, who is Chief Financial Officer at ResMed, sold 5,000 shares at $50.00 on May 12, 2014. Following this transaction, the Chief Financial Officer owned 66,423 shares meaning that the stake was reduced by 7% with the 5,000-share transaction.

The shares most recently traded at $50.79, up $0.79, or 1.56% since the insider transaction. Historical insider transactions for ResMed go as follows:

  • 4-Week # shares sold: 4,290
  • 12-Week # shares sold: 19,890
  • 24-Week # shares sold: 81,577

The average volume for ResMed has been 1.1 million shares per day over the past 30 days. ResMed has a market cap of $7.1 billion and is part of the health care sector and health services industry. Shares are up 9.24% year-to-date as of the close of trading on Monday.

ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The stock currently has a dividend yield of 1.97%. The company has a P/E ratio of 22.2. Currently, there are 4 analysts who rate ResMed a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RMD - FREE

TheStreet Quant Ratings rates ResMed as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full ResMed Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Penn National Gaming (PENN) - FREE Research Report

Jacquemin John M, who is Director at Penn National Gaming, bought 20,000 shares at $10.74 on May 12, 2014. Following this transaction, the Director owned 133,595 shares meaning that the stake was reduced by 17.61% with the 20,000-share transaction.

The shares most recently traded at $11.41, up $0.67, or 5.87% since the insider transaction. Historical insider transactions for Penn National Gaming go as follows:

  • 4-Week # shares bought: 55,000
  • 4-Week # shares sold: 780
  • 12-Week # shares bought: 55,451
  • 12-Week # shares sold: 16,717
  • 24-Week # shares bought: 55,951
  • 24-Week # shares sold: 16,717

The average volume for Penn National Gaming has been 1.6 million shares per day over the past 30 days. Penn National Gaming has a market cap of $881.8 million and is part of the services sector and leisure industry. Shares are down 21.21% year-to-date as of the close of trading on Monday.

Penn National Gaming, Inc., together with its subsidiaries, owns and manages gaming and pari-mutuel properties in the United States and Canada. The company is involved in gaming on slot machines and table games. It operates through three segments: Midwest, East/West, and Southern Plains. The stock currently has a dividend yield of 1%. Currently, there are 9 analysts who rate Penn National Gaming a buy, 2 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PENN - FREE

TheStreet Quant Ratings rates Penn National Gaming as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Penn National Gaming Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Parker Hannifin (PH) - FREE Research Report

Bond Robert W, who is VP/Pres-Fluid Connectors Group at Parker Hannifin, sold 5,674 shares at $125.00 on May 12, 2014. Following this transaction, the VP/Pres-Fluid Connectors Group owned 51,683 shares meaning that the stake was reduced by 9.89% with the 5,674-share transaction.

The shares most recently traded at $126.46, up $1.46, or 1.15% since the insider transaction. Historical insider transactions for Parker Hannifin go as follows:

  • 4-Week # shares sold: 5,043
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 42,350
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 42,350

The average volume for Parker Hannifin has been 1.1 million shares per day over the past 30 days. Parker Hannifin has a market cap of $18.5 billion and is part of the industrial goods sector and industrial industry. Shares are down 1.68% year-to-date as of the close of trading on Monday.

Parker-Hannifin Corporation manufactures motion and control technologies and systems for various mobile, industrial, and aerospace markets worldwide. The stock currently has a dividend yield of 1.55%. The company has a P/E ratio of 18.6. Currently, there are 9 analysts who rate Parker Hannifin a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PH - FREE

TheStreet Quant Ratings rates Parker Hannifin as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Parker Hannifin Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Stocks Slide on Renewed Trade War Concerns

Stocks Slide on Renewed Trade War Concerns

Emerging Markets Get Pounded by Global Trade Concerns

Emerging Markets Get Pounded by Global Trade Concerns

PTC Shares Skyrocket on Positive Data for Spinal Muscular Atrophy Drug

PTC Shares Skyrocket on Positive Data for Spinal Muscular Atrophy Drug

Tesla Slumps After Mary McCormack Tweets Husband's Flaming Model S

Tesla Slumps After Mary McCormack Tweets Husband's Flaming Model S

Stocks Dive Globally as U.S.-China Trade War Intensifies

Stocks Dive Globally as U.S.-China Trade War Intensifies